Return
Interim Results From a Multicenter Observational Safety Study of Patients Treated With Voretigene Neparvovec-rzyl in the United States
A
S
B
J
T
C
R
P
C
D
A
J
D
DOI:10.1016/j.ophtha.2026.07.007.png)
Abstract
En 中文
To assess long-term safety and exploratory ophthalmic outcomes in patients treated with voretigene neparvovec-rzyl (VN) in US clinical practice.
Journal
IF:
9.5
Papers:
1.3W
Citations:
4.4W
Organization
No organization information available
